Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Gilead Sciences discloses new agents for HIV infection

Feb. 1, 2012

Phase II trial investigates GS-7340 as part of a new treatment regimen

Jan. 26, 2012

FDA approves new pediatric formulations of Viread

Jan. 19, 2012

Bristol-Myers Squibb patents novel HIV attachment inhibitors

Jan. 19, 2012

Avixgen patents new candidate drugs for HIV infection

Jan. 19, 2012

Novel agents for HIV infection synthesized in Korea

Jan. 18, 2012

Sumagen set to start phase I testing of new HIV vaccine

Jan. 17, 2012

DFH Pharma and NCI enter collaboration

Jan. 13, 2012

Sangamo BioSciences begins two phase II trials in HIV

Jan. 12, 2012

Clinical study of intranasally administered HIV vaccine fully enrolled

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...